Provided by Tiger Trade Technology Pte. Ltd.

Kazia Therapeutics Limited

12.79
+4.3451.36%
Pre-market: 12.70-0.0900-0.70%04:04 EST
Volume:1.44M
Turnover:16.97M
Market Cap:21.37M
PE:-1.03
High:14.42
Open:8.29
Low:8.11
Close:8.45
52wk High:29.00
52wk Low:2.86
Shares:1.67M
Float Shares:1.48M
Volume Ratio:0.21
T/O Rate:97.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.3849
EPS(LYR):-12.3849
ROE:-3891.64%
ROA:-64.28%
PB:-3.96
PE(LYR):-1.03

Loading ...

Kazia Therapeutics Announces Breakthrough in Ex Vivo Study: Paxalisib Monotherapy Disrupts Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer

Reuters
·
Sep 11

Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage Iv Her2-Positive Breast Cancer With Paxalisib Monotherapy

THOMSON REUTERS
·
Sep 11

BRIEF-Kazia Therapeutics Announces $2 Million Private Placement At Premium To Market

Reuters
·
Aug 01

Kazia Therapeutics Secures $2 Million in Premium Private Placement to Advance Cancer Drug Development

Reuters
·
Aug 01

Kazia Therapeutics Ltd - Proceeds to Support Clinical Development of Paxalisib and EVT801

THOMSON REUTERS
·
Aug 01

Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market

THOMSON REUTERS
·
Aug 01

Top Premarket Decliners

MT Newswires Live
·
Jul 28

Kazia Therapeutics Limited Files Prospectus for At the Market Offering of American Depositary Shares

Reuters
·
Jul 26

Kazia Therapeutics Announces Promising Early Results in Phase 1b Trial for Triple-Negative Breast Cancer with Paxalisib Combination Therapy

Reuters
·
Jul 09

Top Midday Gainers

MT Newswires Live
·
Jun 12

BUZZ-U.S. STOCKS ON THE MOVE-Vaxart, DoubleVerify, Cracker Barrel

Reuters
·
Jun 12

BRIEF-Kazia Therapeutics Announces Transformative Preclinical Data

Reuters
·
Jun 11

Kazia Therapeutics Launches Phase 1b Clinical Trial of Paxalisib in Combination with Immunotherapy for Advanced Breast Cancer

Reuters
·
Jun 11

Kazia Therapeutics Limited Launches Phase 1b Trial of Paxalisib in Advanced Breast Cancer, Dosing First Patient

Reuters
·
Jun 05

Kazia Therapeutics Limited Conducted Annual General Meeting Online

Reuters
·
May 29